Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Grifols SA ADR stock

Learn how to easily invest in Grifols SA ADR stock.

Grifols SA ADR is a drug manufacturers-general business based in the US. Grifols SA ADR shares (GRFS) are listed on the NASDAQ and all prices are listed in US Dollars. Grifols SA ADR employs 23,631 staff and has a trailing 12-month revenue of around $6.5 billion.

How to buy Grifols SA ADR stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – GRFS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Grifols SA ADR stock price (NASDAQ: GRFS)

Use our graph to track the performance of GRFS stocks over time.

Grifols SA ADR shares at a glance

Information last updated 2023-09-20.
Latest market close$9.40
52-week range$5.71 - $10.97
50-day moving average $9.91
200-day moving average $8.80
Wall St. target price$13.92
PE ratio 54.1667
Dividend yield $0 (7.09%)
Earnings per share (TTM) $0.18

Buy Grifols SA ADR stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Grifols SA ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Grifols SA ADR price performance over time

Historical closes compared with the close of $9.4 from 2023-09-22

1 week (2023-09-15) -4.95%
1 month (2023-08-24) -3.39%
3 months (2023-06-23) 5.26%
6 months (2023-03-24) 37.23%
1 year (2022-09-23) 33.71%
2 years (2021-09-24) -38.52%
3 years (2020-09-24) 16.0783
5 years (2018-09-24) 19.8235

Is Grifols SA ADR stock undervalued or overvalued?

Valuing Grifols SA ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Grifols SA ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Grifols SA ADR financials

Revenue TTM $6.5 billion
Operating margin TTM 9.47%
Gross profit TTM $2.2 billion
Return on assets TTM 1.81%
Return on equity TTM 1.24%
Profit margin 0.13%
Book value $4.32
Market Capitalization $8.2 billion

TTM: trailing 12 months

Grifols SA ADR share dividends

We're not expecting Grifols SA ADR to pay a dividend over the next 12 months.

Have Grifols SA ADR's shares ever split?

Grifols SA ADR's shares were split on a 2:1 basis on 3 January 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Grifols SA ADR shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Grifols SA ADR shares which in turn could have impacted Grifols SA ADR's share price.

Grifols SA ADR share price volatility

Over the last 12 months, Grifols SA ADR's shares have ranged in value from as little as $5.71 up to $10.965. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Grifols SA ADR's is 0.4572. This would suggest that Grifols SA ADR's shares are less volatile than average (for this exchange).

Grifols SA ADR overview

Grifols, S. A. operates as a plasma therapeutic company in Spain, the United States, Canada and internationally. The Biopharma segment provides plasma derivatives products, including Gamunex/Gamunex-C Immune Globulin Injection, Flebogamma Immune Globulin Intravenous, Xembify Immune Globulin Subcutaneous solution, HyperRAB Rabies Immune Globulin, Prolastin/Prolastin-C/Prolastin-C Liquid/Prolasplan/Prolastina/Pulmolast/Lynspad Alpha 1-Proteinase Inhibitor, Fanhdi and Alphanate, Antihemophilic Factor/von Willebrand factor Complex, Koate-DVI Antihemophilic Factor, Albutein/Albutein Flexbag/ Human Albumin Grifols/Plasbumin Albumin, and Vistaseal/Veraseal; and Tavlesse, a non-plasma derivative medicinal product. The Diagnostic segment offers transfusion medicine, which includes Procleix Panther systems/Procleix Panther with Automation Ready technology, Automated NAT blood screening systems, assays, software, WADiana/Erytra/Erytra Eflexys analyzers, BLOODchip ID/IDCore/IDHPA/IDRHD/IDCORE/BIDS, and antigens; and clinical and diagnostics products, such as Promonitor and Alpha1D. The Bio Supplies segment provides human biological materials for life sciences research and the development and manufacturing of pharmaceutical and diagnostic products. The Others segment offers healthcare solutions, which provides services and manufactures products, including parenteral solutions, robotics, and software used by hospitals, blood banks, plasma collection centers and other healthcare systems.

Frequently asked questions

What percentage of Grifols SA ADR is owned by institutions?
Currently 46.276% of Grifols SA ADR shares are held by institutions.
How many people work for Grifols SA ADR?
Latest data suggests 23,631 work at Grifols SA ADR.
When does the fiscal year end for Grifols SA ADR?
Grifols SA ADR's fiscal year ends in December.
Where is Grifols SA ADR based?
Grifols SA ADR's address is: Avinguda de la Generalitat, 152, Barcelona, Spain, 08174
What is Grifols SA ADR's ISIN number?
Grifols SA ADR's international securities identification number is: US3984384087
What is Grifols SA ADR's CUSIP number?
Grifols SA ADR's Committee on Uniform Securities Identification Procedures number is: 398438200

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site